The Vanity Factor

The Vanity Factor

There’s a reason a historical perspective combined with “real” facts leads to common sense conclusions. Unlike what we are seeing as analysts who lack historical perspective and don’t bother to learn the facts spout their uninformed mostly useless opinions. Only problem is investors who rely on these analysts to provide informed analysis act on them. This is exactly what happened Tuesday when diabetes technology stocks git hammered.

All of a sudden drugs like Ozempic Wegovy and Mounjaro are now the greatest thing ever and every person with diabetes (PWD) will use them. There will be no need for . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.